MGD… Unplugged!
New Developments, Treatment Considerations,
             Case Reviews


            Aaron Wolf, O.D.
Sources
• The International Workshop on Meibomian Gland
  Dysfunction
    – Investigative Ophthalmology & Visual Science, March 2011
    – >50 international experts, M.D.’s, O.D.’s, Ph.D’s; >2 year period
•   The Tear Film and Ocular Surface Society
•   The Ocular Surface
•   Ophthalmology Management
•   Optometric Management
•   Review of Optometry
•   Contact Lens Spectrum
•   Personal observations and experiences in clinical practice
MGD – Recommended Definition
Meibomian gland dysfunction (MGD) is a
 chronic, diffuse abnormality of the meibomian
 glands, commonly characterized by terminal
 duct obstruction and/or
 qualitative/quantitative changes in the
 glandular secretion. This may result in
 alteration of the tear film, symptoms of eye
 irritation, clinically apparent
 inflammation, and ocular surface disease.
Definition and Classification of MGD
•   MGD
•   Blepharitis: general term describing inflammation of the lid as a whole
     – Marginal Bepharitis: inflammation of the lid margin; includes both anterior and posterior blepharitis
     – Anterior Blepharitis: inflammation of lid margin anterior to gray line and centered around the lashes
     – Posterior Blepharitis: inflammation of posterior lid margin, of which MGD is only one cause (e.g.
       infectious, allergic)
•   Meibomian Gland Disease: used to describe a broader range of meibomian gland
    disorders, including neoplasia and congenital disease
•   Meibomitis/Meibomianitis: subset of MGD associated with inflammation of meibomian
    glands
•   Hypersecretory MGD/Seborrheic MGD: MGD with increased secretion of meibomian
    lipids
•   Hyposecretory MGD: decreased lipid secretion without obstruction of glands (result of CL
    wear?)
•   Obstructive MGD: decreased lipid secretion due to obstruction of meibomian glands.
    PROBABLY MOST COMMON FORM OF MGD.
•   COMD - Chronic Obstructive Meibomian Disease
•   NOMGD – Non-Obvious MGD: normal appearance of lids and gland orifices; found only
    by expression
MGD...Unplugged
Prevalence
The International Workshop on Meibomian Gland Dysfunction:

“MGD may well be the leading cause of dry eye disease throughout
  the world.”

“…of the two currently accepted forms of dry eye, evaporative dry eye
  is thought to be significantly more common than aqueous-
  deficient dry eye.”

• 3.5%-69.3%
   – Results vary widely depending on study populations (age, race) and
     lack of universal criteria for grading signs associated with MGD.
Tear Film Lipid Layer Function
1. Provide a smooth optical surface for the cornea
   at the air-lipid interface
2. Reduce evaporation of the tear film
3. Enhance the stability of the tear film
4. Enhance spreading of the tear film
5. Prevent spillover of tears from the lid margin
6. Prevent contamination of the tear film by
   microbial agents and organic matter
7. Seal the apposing lid margins during sleep
Causes, Contributing Factors
•   Blinking Inhibition
     – computer work, reading, TV, video games
•   Contact Lens wear
     – Artificial surface, friction, keratinization, deposits, GPC
•   Age
•   Race
•   Gender
•   Hormonal disturbance
     – Androgen insufficiency, menopause, sex hormones, steroids, growth factors
•   Medications
     – Accutane, hormone therapy, BPH meds, antihistamines, antidepressants, etc.
•   Systemic/Dermatologic disease
     – Acne rosacea, acne vulgaris, eczema, psoriasis, seborrhea, atopy, Sjogren’s
•   Ophthalmic disease
     – Anterior blepharitis, contact lens wear, Demodex folliculorum, dry eye disease
•   Lipid profiles/dyslipidemia
•   Epithelial overgrowth
•   Environmental
     – Geography, temperature, humidity, ceiling fans, car air vents, pollution, allergens
Symptoms
•   Dryness            • Eyelid redness
•   Redness            • Eyelid itching
•   Watering/tearing   • Crust on lids/lashes,
•   Burning/stinging     especially in mornings
•   Eye irritation     • Eyelids stuck together,
•   Itchy eyes           especially in mornings
•   Gritty/sandy       • Puffy eyelids
•   Sticky sensation   • Sensitivity to light
                       • Increased glare
Anatomy & Physiology
• Arrangement
   – Parallel, length of tarsal plate, UL
     longer than LL
• Number of glands
   – Depending on study, UL: 25-40 and
     LL: 20-30
   – Total volume of UL glands
     approximately double that of LL
     glands
   – Central duct wider in lower lid
   – Insufficient studies to date as to
     which lid and where secretes most
     sebum (Nasal 1/3 or LL may be
     faulty given volume of UL glands)
Anatomy & Physiology
• Pathway of meibum
   1.   Secretory acini filled with
        meibocytes create meibum
   2.   Short, lateral connecting
        ductule
   3.   Long, central duct
   4.   Excretory duct
   5.   Lipid reservoir
   6.   Tear film
• Driving force of meibum delivery
   – Continuous secretion of meibum
   – Mechanical muscular action of
     blink
• Recovery time after full
  expression: approx. 2 hours
• Meibum melting point: 82-89F
Pathophysiology of MGD




Hyperkeratinization of excretory duct and orifice/ Altered
  lipid compensation → obstruction → increased
  intraglandular pressure → degenerative dilatation of
  ductal system → hyposecretion due to loss of meibocytes
  → gland atrophy → cell stress may ultimately trigger
  downstream occurrence of inflammation
Clinical Systematic Evaluation
1. Symptom Questionnaire

2. Eyelids

3. Meibomian Glands

4. Tear Film

5. Ocular Surface
Symptom Questionnaire
• Does not distinguish between MGD and dry eye, or
  between aqueous deficient dry eye (ADDES) and
  evaporative dry eye (EDES)
• Patients likely to develop over time elements of both
  ADDES and EDES
• Not always high correlation of signs and symptoms
• Source of symptoms from meibomian glands or from
  ocular surface?
• MGD risk factor or cause of dry eye? Or dry eye risk
  factor or cause of MGD?
• Timeline of events or severity before symptoms
  develop?
Eyelids
• Telangiectasia              • Anterior blepharitis
• Overall lid margin          • Tenderness to touch
  injection/hyperemia         • Lid wiper epitheliopathy
• Lid margin keratinization   • Epithelial ridge
• Eyelid thickening             formation between
• Dimpling/notching/pitting     meibomian glands
• Meibomian gland             • Distichiasis
  concretions
Eyelid
Abnormalities
Meibomian Glands
    Meibography/Meiboscopy!!           Express!, Express!, Express!
•   Atrophy of terminal ducts      •    Number of functional glands
•   Absence of entire glands       •    Obstructive capping/plugging
•   Scarring of orifice            •    Expressibility
•   Obstructive capping/plugging   •    Color of meibum
•   Microchalazia/lipogranulomas   •    Consistency of meibum
•   Meibomian gland concretions
MGD...Unplugged
MGD...Unplugged
Tear Film
               ADDES vs. EDES vs. combination

            Quantity                            Quality
• TBUT                             •   TBUT pattern
• Ocular Protective Index          •   Frothy tear film
  (OPI) and Blink Rate (BR)
                                   •   Debris in tear film
• Meniscus height/depth
    – Measured prior to NaFl dye
                                   •   Osmolarity
    – OCT measurement of depth     •   Interferometry
•   Schirmer test                  •   Evaluate in both white light
•   Phenol Red Test                    and with fluorescein
•   Osmolarity
•   Interferometry
Palpated lid OD, untouched lid OS
Ocular Surface
• Increased evaporation of tear film →
  increased hyperosmolarity → inflammatory
  response → damage to ocular surface
  epithelia
• Corneal staining: Fluorescein
• Conjunctival staining: Lissamine Green
Treatment Options
FDA approved meds for MGD?? = None!
• Topical Rx
• Oral Rx
• OTC topical
• Nutritional
• Home therapy
• “Surgical” Procedures
• Contact Lens considerations
Topical Rx Therapeutics
• AzaSite, erythromycin
    – inhibit protein synthesis; Coverage and penetration of AzaSite >> erythromycin
    – immunomodulatory and anti-inflammatory effects; mechanism unclear
• Besivance, et al fluoroquinilones
    – Minimal ocular surface toxicity; excellent coverage
• Combo’s: Tobradex, Tobradex ST, Zylet
• Restasis
• FreshKote
    – Supplements all 3 layers; improves stability by increasing adhesion of molecules
• metronidazole 1% ointment
    – Antibiotic for rosacea; mechanism unclear
• Tea tree shampoo QD, 50% tea tree oil QW in presence of Demodex
    – No evidence yet that Demodex can cause MGD
• Steroids?
• NSAIDs??
Oral Rx Therapeutics
• Tetracycline derivatives
   – Tetracycline 250mg QD-QID: anti-inflammatory, not anti-
     microbial
   – Doxycycline 50-100mg QD-BID: anti-
     inflammatory, potentially mildly anti-microbial
   – Minocycline 50-100mg QD-BID: Both anti-inflammatory
     and anti-microbial
   – Suppresses microbial lipase production, which is
     responsible for release of pro-inflammatory FFA’s and
     diglycerides
   – Usually well-tolerated; be knowledgeable of side effects
• Erythromycin
   – Children and women
• Video of tbut 6mo on doxy 100mg
OTC Topical “therapeutics”
•   Systane Balance    • Preservative-free?
•   Soothe XP          • Best served cold?
•   Blink Tears        • Gel, ointment ?
•   Refresh Optive
•   Systane Ultra
•   …and many others
Nutritional
• Essential fatty acids: Omega-3,6,9
  – Omega-3,9 vs. Omega-6
  – Fish oil vs. flaxseed oil
  – No consensus on dosing yet
• Hydration vs. dehydration
• Spicy foods, and other triggers of rosacea
• Fatty foods
Home Therapy & Maintenance
• Warm compresses with lid
  massage/digital expression
  still gold standard
• Forceful blinks with lid
  massage
• Lid scrubs, saline-soaked
  cotton tip scrub
• Hot/Cold goggles, face
  masks
• Moisture Release Eyewear
• Humidifiers
In-office “Surgical” Procedures
• Professional forceful expression
  – Mastrota Meibomian Paddle; OcuSoft
  – MG Expressor; Gulden Ophthalmics
• Maskin Intraductal Probes and Tubes
  – Rhein Medical; Probes: 10/box $150; 50/box $750
• Intense Pulsed Light (IPL) therapy
  – rosacea and other dermatological conditions;
    high-intensity broad spectrum light pulses
• Punctal/Intracanalicular Plugs
• Video of mastrota expression
• Video of mastrota + MG expressor
• Video of maskin probing
Contact Lens Considerations
• Daily disposable lenses
• Thin edge lenses
• Low water content vs. High water content
• No significant difference in evaporation between
  hydrogels vs. SiHy’s, but worse than non-wearers
• Lipid deposits substantially higher in silicone
  hydrogels than conventional hydrogels
    – lotrafilcon A (Ciba) < galyfilcon A (Acuvue) < balafilcon A (B&L)
• Hydrogen peroxide based solutions
Case Examples
Billing
•   Examination, 92002, 92012, 92004, 92014, E/M level codes:
•   External Photography, 92285: $27.64, bilateral
•   OCT of anterior segment, 92132: $36.05, bilateral
•   Tear Osmolarity, 83861: $24.01, unilateral, when CLIA
    Waiver categorization from FDA
•   Interferometry, 92136: $82.49, bilateral
•   Punctum Plug, 68761: $140.20, E1-E4
•   Evacuation of Meibomian Glands, 0207T: unilateral,
    Category III code
•   Advanced Beneficiary Notice of Noncoverage (ABN)
•   Informed Consent
My Recommendations from
                      Experience
• Mastrota Meibomian Paddle forceful               • Maskin Intraductal Probing
  expressions                                          – Pre-Op:
   – Pre-Op:                                               • prior forceful expression preferred to
       • prior digital palpation preferred to                understand which glands to target
         understand which glands to target                 • Insertion of BCL to protect cornea from
       • Insertion of BCL to protect cornea from             anesthetics
         anesthetics                                       • TetraVisc Forte ophthalmic gel
       • TetraVisc Forte ophthalmic gel                    • Compounded lidocaine 4% jelly in fornix
       • Compounded lidocaine 4% jelly in fornix             and lid margin
         and lid margin                                    • WC for 20 minutes
       • EMLA cream to dermal side of lids             – Post-Op:
       • WC for 20 minutes                                 • Irrigate eye and everted lids with
   – Post-Op:                                                eyewash
       • Irrigate eye and everted lids with                • Remove BCL
         eyewash                                           • In-office antibiotic
       • Remove BCL                                        • In-office NSAID
       • In-office antibiotic                              • Tobradex ST QID x2d
       • In-office NSAID                                   • AzaSite qhs
       • Tobradex ST QID x2d                               • PF Blink/Optive/Systane
       • AzaSite qhs                                       • RTC 1-2wks
       • PF Blink/Optive/Systane
       • RTC depends on diagnostic outcome of
         procedure
What’s in the Pipeline?
• Tear Science LipiFlow Thermal Pulsation System – not
  approved in U.S. yet
• Maskin Meibum Expressor, Rhein Medical, launches mid-July
• Resolvyx RX-10045, topical resolvin
• Remura (bromfenac for dry eye), ISTA
  Pharmaceuticals, Phase III
• T-Pred (tobramycin 3%, prednisolone acetate 1%), ISTA
  Pharmaceuticals, likely enter Phase III in 2012
• Can-Fite CF101, oral anti-inflammatory, Phase III for DES and
  psoriasis, ongoing studies for rheumatoid arthritis and
  glaucoma
• Zylet ointment?? – come on Bausch&Lomb!!
Take Home Points
 Understand the differences in terminology; THEY
  ARE NOT SYNONYMOUS
 Distinguish the difference clinically between
  ADDES and EDES and treat specifically, not
  generically
 Develop a clinical evaluation routine. CEE’s may
  not be the same as targeted dry eye evaluations
 Consider the possible long-term effects of contact
  lens wear modalities
 Be the EXPERT for your patients. This is OUR
  specialty!
Questions??

More Related Content

PPTX
Intermitent exotropia
PPTX
Retina drwaing
PPTX
keratoprosthesis
PPT
Pellucid marginal degeneration
PPTX
Epiretinal membrane
PPTX
Pseudoexfoliation syndrome
PPTX
Anterior segment OCT & UBM
PPTX
Bandage Contact Lens
Intermitent exotropia
Retina drwaing
keratoprosthesis
Pellucid marginal degeneration
Epiretinal membrane
Pseudoexfoliation syndrome
Anterior segment OCT & UBM
Bandage Contact Lens

What's hot (20)

PPTX
Malingering (Case presentation)
PPT
NW2010 Epiretinal membrane
PPTX
Direct & indirect ophthalmoscopy
PPTX
Keratoplasty
PPTX
Femtosecond laser assisted cataract surgery
PPTX
Managing the failing bleb
PPTX
MACULAR DYSTROPHIES
PPTX
Corneal collagen cross linking
PPTX
Malignant Glaucoma
PPTX
Choroidal neovascularisation(cnv)
PPTX
Lamellar keratoplasty
PPTX
The limbus
PPTX
Macular hole
PPT
Squint assessment
PPT
Coats' Disease
PPTX
PPTX
Exodeviations , Exotropia
PPTX
pentacam
PPTX
Diabetic retinopathy Trials
Malingering (Case presentation)
NW2010 Epiretinal membrane
Direct & indirect ophthalmoscopy
Keratoplasty
Femtosecond laser assisted cataract surgery
Managing the failing bleb
MACULAR DYSTROPHIES
Corneal collagen cross linking
Malignant Glaucoma
Choroidal neovascularisation(cnv)
Lamellar keratoplasty
The limbus
Macular hole
Squint assessment
Coats' Disease
Exodeviations , Exotropia
pentacam
Diabetic retinopathy Trials
Ad

Similar to MGD...Unplugged (20)

PPTX
Meibomian unplugged
PPT
Prof Bron lecture. The A-Z of MGD
PDF
Comprehensive meibomian gland evaluation
PDF
Blepharitis
PPTX
MEIBOMIAN GLAND DYsfunction.pptx
PPTX
ocular surface lecture.pptx
PPTX
Eyelid Infections & Blepharitis Dr. Prabhat Devkota.pptx
PPTX
Meibography
PDF
Tear dysfunction syndrome: Microstructural findings in vivo
PPTX
Dry Eye causes, aetiology, pathogenesis, treatment.pptx
PPTX
Meibomian gland dysfunction
PPTX
Dry eye: An Overview
PPTX
Blepharitis
PPTX
Ophthalmology
PPTX
Dry eye management ppt
PPT
Ophthalmology 5th year, 1st & 2nd lectures (Dr. Khalid)
PPTX
Dry eye presentation latest-Dr Dildar Singh
PPTX
Dry eye ppt by dr dildar
PPTX
New Trends in Ocular Surface Treartment
Meibomian unplugged
Prof Bron lecture. The A-Z of MGD
Comprehensive meibomian gland evaluation
Blepharitis
MEIBOMIAN GLAND DYsfunction.pptx
ocular surface lecture.pptx
Eyelid Infections & Blepharitis Dr. Prabhat Devkota.pptx
Meibography
Tear dysfunction syndrome: Microstructural findings in vivo
Dry Eye causes, aetiology, pathogenesis, treatment.pptx
Meibomian gland dysfunction
Dry eye: An Overview
Blepharitis
Ophthalmology
Dry eye management ppt
Ophthalmology 5th year, 1st & 2nd lectures (Dr. Khalid)
Dry eye presentation latest-Dr Dildar Singh
Dry eye ppt by dr dildar
New Trends in Ocular Surface Treartment
Ad

MGD...Unplugged

  • 1. MGD… Unplugged! New Developments, Treatment Considerations, Case Reviews Aaron Wolf, O.D.
  • 2. Sources • The International Workshop on Meibomian Gland Dysfunction – Investigative Ophthalmology & Visual Science, March 2011 – >50 international experts, M.D.’s, O.D.’s, Ph.D’s; >2 year period • The Tear Film and Ocular Surface Society • The Ocular Surface • Ophthalmology Management • Optometric Management • Review of Optometry • Contact Lens Spectrum • Personal observations and experiences in clinical practice
  • 3. MGD – Recommended Definition Meibomian gland dysfunction (MGD) is a chronic, diffuse abnormality of the meibomian glands, commonly characterized by terminal duct obstruction and/or qualitative/quantitative changes in the glandular secretion. This may result in alteration of the tear film, symptoms of eye irritation, clinically apparent inflammation, and ocular surface disease.
  • 4. Definition and Classification of MGD • MGD • Blepharitis: general term describing inflammation of the lid as a whole – Marginal Bepharitis: inflammation of the lid margin; includes both anterior and posterior blepharitis – Anterior Blepharitis: inflammation of lid margin anterior to gray line and centered around the lashes – Posterior Blepharitis: inflammation of posterior lid margin, of which MGD is only one cause (e.g. infectious, allergic) • Meibomian Gland Disease: used to describe a broader range of meibomian gland disorders, including neoplasia and congenital disease • Meibomitis/Meibomianitis: subset of MGD associated with inflammation of meibomian glands • Hypersecretory MGD/Seborrheic MGD: MGD with increased secretion of meibomian lipids • Hyposecretory MGD: decreased lipid secretion without obstruction of glands (result of CL wear?) • Obstructive MGD: decreased lipid secretion due to obstruction of meibomian glands. PROBABLY MOST COMMON FORM OF MGD. • COMD - Chronic Obstructive Meibomian Disease • NOMGD – Non-Obvious MGD: normal appearance of lids and gland orifices; found only by expression
  • 6. Prevalence The International Workshop on Meibomian Gland Dysfunction: “MGD may well be the leading cause of dry eye disease throughout the world.” “…of the two currently accepted forms of dry eye, evaporative dry eye is thought to be significantly more common than aqueous- deficient dry eye.” • 3.5%-69.3% – Results vary widely depending on study populations (age, race) and lack of universal criteria for grading signs associated with MGD.
  • 7. Tear Film Lipid Layer Function 1. Provide a smooth optical surface for the cornea at the air-lipid interface 2. Reduce evaporation of the tear film 3. Enhance the stability of the tear film 4. Enhance spreading of the tear film 5. Prevent spillover of tears from the lid margin 6. Prevent contamination of the tear film by microbial agents and organic matter 7. Seal the apposing lid margins during sleep
  • 8. Causes, Contributing Factors • Blinking Inhibition – computer work, reading, TV, video games • Contact Lens wear – Artificial surface, friction, keratinization, deposits, GPC • Age • Race • Gender • Hormonal disturbance – Androgen insufficiency, menopause, sex hormones, steroids, growth factors • Medications – Accutane, hormone therapy, BPH meds, antihistamines, antidepressants, etc. • Systemic/Dermatologic disease – Acne rosacea, acne vulgaris, eczema, psoriasis, seborrhea, atopy, Sjogren’s • Ophthalmic disease – Anterior blepharitis, contact lens wear, Demodex folliculorum, dry eye disease • Lipid profiles/dyslipidemia • Epithelial overgrowth • Environmental – Geography, temperature, humidity, ceiling fans, car air vents, pollution, allergens
  • 9. Symptoms • Dryness • Eyelid redness • Redness • Eyelid itching • Watering/tearing • Crust on lids/lashes, • Burning/stinging especially in mornings • Eye irritation • Eyelids stuck together, • Itchy eyes especially in mornings • Gritty/sandy • Puffy eyelids • Sticky sensation • Sensitivity to light • Increased glare
  • 10. Anatomy & Physiology • Arrangement – Parallel, length of tarsal plate, UL longer than LL • Number of glands – Depending on study, UL: 25-40 and LL: 20-30 – Total volume of UL glands approximately double that of LL glands – Central duct wider in lower lid – Insufficient studies to date as to which lid and where secretes most sebum (Nasal 1/3 or LL may be faulty given volume of UL glands)
  • 11. Anatomy & Physiology • Pathway of meibum 1. Secretory acini filled with meibocytes create meibum 2. Short, lateral connecting ductule 3. Long, central duct 4. Excretory duct 5. Lipid reservoir 6. Tear film • Driving force of meibum delivery – Continuous secretion of meibum – Mechanical muscular action of blink • Recovery time after full expression: approx. 2 hours • Meibum melting point: 82-89F
  • 12. Pathophysiology of MGD Hyperkeratinization of excretory duct and orifice/ Altered lipid compensation → obstruction → increased intraglandular pressure → degenerative dilatation of ductal system → hyposecretion due to loss of meibocytes → gland atrophy → cell stress may ultimately trigger downstream occurrence of inflammation
  • 13. Clinical Systematic Evaluation 1. Symptom Questionnaire 2. Eyelids 3. Meibomian Glands 4. Tear Film 5. Ocular Surface
  • 14. Symptom Questionnaire • Does not distinguish between MGD and dry eye, or between aqueous deficient dry eye (ADDES) and evaporative dry eye (EDES) • Patients likely to develop over time elements of both ADDES and EDES • Not always high correlation of signs and symptoms • Source of symptoms from meibomian glands or from ocular surface? • MGD risk factor or cause of dry eye? Or dry eye risk factor or cause of MGD? • Timeline of events or severity before symptoms develop?
  • 15. Eyelids • Telangiectasia • Anterior blepharitis • Overall lid margin • Tenderness to touch injection/hyperemia • Lid wiper epitheliopathy • Lid margin keratinization • Epithelial ridge • Eyelid thickening formation between • Dimpling/notching/pitting meibomian glands • Meibomian gland • Distichiasis concretions
  • 17. Meibomian Glands Meibography/Meiboscopy!! Express!, Express!, Express! • Atrophy of terminal ducts • Number of functional glands • Absence of entire glands • Obstructive capping/plugging • Scarring of orifice • Expressibility • Obstructive capping/plugging • Color of meibum • Microchalazia/lipogranulomas • Consistency of meibum • Meibomian gland concretions
  • 20. Tear Film ADDES vs. EDES vs. combination Quantity Quality • TBUT • TBUT pattern • Ocular Protective Index • Frothy tear film (OPI) and Blink Rate (BR) • Debris in tear film • Meniscus height/depth – Measured prior to NaFl dye • Osmolarity – OCT measurement of depth • Interferometry • Schirmer test • Evaluate in both white light • Phenol Red Test and with fluorescein • Osmolarity • Interferometry
  • 21. Palpated lid OD, untouched lid OS
  • 22. Ocular Surface • Increased evaporation of tear film → increased hyperosmolarity → inflammatory response → damage to ocular surface epithelia • Corneal staining: Fluorescein • Conjunctival staining: Lissamine Green
  • 23. Treatment Options FDA approved meds for MGD?? = None! • Topical Rx • Oral Rx • OTC topical • Nutritional • Home therapy • “Surgical” Procedures • Contact Lens considerations
  • 24. Topical Rx Therapeutics • AzaSite, erythromycin – inhibit protein synthesis; Coverage and penetration of AzaSite >> erythromycin – immunomodulatory and anti-inflammatory effects; mechanism unclear • Besivance, et al fluoroquinilones – Minimal ocular surface toxicity; excellent coverage • Combo’s: Tobradex, Tobradex ST, Zylet • Restasis • FreshKote – Supplements all 3 layers; improves stability by increasing adhesion of molecules • metronidazole 1% ointment – Antibiotic for rosacea; mechanism unclear • Tea tree shampoo QD, 50% tea tree oil QW in presence of Demodex – No evidence yet that Demodex can cause MGD • Steroids? • NSAIDs??
  • 25. Oral Rx Therapeutics • Tetracycline derivatives – Tetracycline 250mg QD-QID: anti-inflammatory, not anti- microbial – Doxycycline 50-100mg QD-BID: anti- inflammatory, potentially mildly anti-microbial – Minocycline 50-100mg QD-BID: Both anti-inflammatory and anti-microbial – Suppresses microbial lipase production, which is responsible for release of pro-inflammatory FFA’s and diglycerides – Usually well-tolerated; be knowledgeable of side effects • Erythromycin – Children and women
  • 26. • Video of tbut 6mo on doxy 100mg
  • 27. OTC Topical “therapeutics” • Systane Balance • Preservative-free? • Soothe XP • Best served cold? • Blink Tears • Gel, ointment ? • Refresh Optive • Systane Ultra • …and many others
  • 28. Nutritional • Essential fatty acids: Omega-3,6,9 – Omega-3,9 vs. Omega-6 – Fish oil vs. flaxseed oil – No consensus on dosing yet • Hydration vs. dehydration • Spicy foods, and other triggers of rosacea • Fatty foods
  • 29. Home Therapy & Maintenance • Warm compresses with lid massage/digital expression still gold standard • Forceful blinks with lid massage • Lid scrubs, saline-soaked cotton tip scrub • Hot/Cold goggles, face masks • Moisture Release Eyewear • Humidifiers
  • 30. In-office “Surgical” Procedures • Professional forceful expression – Mastrota Meibomian Paddle; OcuSoft – MG Expressor; Gulden Ophthalmics • Maskin Intraductal Probes and Tubes – Rhein Medical; Probes: 10/box $150; 50/box $750 • Intense Pulsed Light (IPL) therapy – rosacea and other dermatological conditions; high-intensity broad spectrum light pulses • Punctal/Intracanalicular Plugs
  • 31. • Video of mastrota expression • Video of mastrota + MG expressor • Video of maskin probing
  • 32. Contact Lens Considerations • Daily disposable lenses • Thin edge lenses • Low water content vs. High water content • No significant difference in evaporation between hydrogels vs. SiHy’s, but worse than non-wearers • Lipid deposits substantially higher in silicone hydrogels than conventional hydrogels – lotrafilcon A (Ciba) < galyfilcon A (Acuvue) < balafilcon A (B&L) • Hydrogen peroxide based solutions
  • 34. Billing • Examination, 92002, 92012, 92004, 92014, E/M level codes: • External Photography, 92285: $27.64, bilateral • OCT of anterior segment, 92132: $36.05, bilateral • Tear Osmolarity, 83861: $24.01, unilateral, when CLIA Waiver categorization from FDA • Interferometry, 92136: $82.49, bilateral • Punctum Plug, 68761: $140.20, E1-E4 • Evacuation of Meibomian Glands, 0207T: unilateral, Category III code • Advanced Beneficiary Notice of Noncoverage (ABN) • Informed Consent
  • 35. My Recommendations from Experience • Mastrota Meibomian Paddle forceful • Maskin Intraductal Probing expressions – Pre-Op: – Pre-Op: • prior forceful expression preferred to • prior digital palpation preferred to understand which glands to target understand which glands to target • Insertion of BCL to protect cornea from • Insertion of BCL to protect cornea from anesthetics anesthetics • TetraVisc Forte ophthalmic gel • TetraVisc Forte ophthalmic gel • Compounded lidocaine 4% jelly in fornix • Compounded lidocaine 4% jelly in fornix and lid margin and lid margin • WC for 20 minutes • EMLA cream to dermal side of lids – Post-Op: • WC for 20 minutes • Irrigate eye and everted lids with – Post-Op: eyewash • Irrigate eye and everted lids with • Remove BCL eyewash • In-office antibiotic • Remove BCL • In-office NSAID • In-office antibiotic • Tobradex ST QID x2d • In-office NSAID • AzaSite qhs • Tobradex ST QID x2d • PF Blink/Optive/Systane • AzaSite qhs • RTC 1-2wks • PF Blink/Optive/Systane • RTC depends on diagnostic outcome of procedure
  • 36. What’s in the Pipeline? • Tear Science LipiFlow Thermal Pulsation System – not approved in U.S. yet • Maskin Meibum Expressor, Rhein Medical, launches mid-July • Resolvyx RX-10045, topical resolvin • Remura (bromfenac for dry eye), ISTA Pharmaceuticals, Phase III • T-Pred (tobramycin 3%, prednisolone acetate 1%), ISTA Pharmaceuticals, likely enter Phase III in 2012 • Can-Fite CF101, oral anti-inflammatory, Phase III for DES and psoriasis, ongoing studies for rheumatoid arthritis and glaucoma • Zylet ointment?? – come on Bausch&Lomb!!
  • 37. Take Home Points  Understand the differences in terminology; THEY ARE NOT SYNONYMOUS  Distinguish the difference clinically between ADDES and EDES and treat specifically, not generically  Develop a clinical evaluation routine. CEE’s may not be the same as targeted dry eye evaluations  Consider the possible long-term effects of contact lens wear modalities  Be the EXPERT for your patients. This is OUR specialty!

Editor's Notes

  • #4: Dysfunction: disease process, but main issue is function of glands is disturbed, leading to instability (evaporation, increased surface tension, unsealed lids during sleep) and possible symptomsDiffuse: involves most of glands. Localized involvement (chalazion) doesn’t cause abnormalities in tear film or ocular surface, therefore not part of MGDObstruction: most prominent aspect of MGD
  • #5: Hypersecretory: hyperresponse of glands to androgens is most likely explanation. Not assoc. w/ inflammation and normal appearance w/ meibography. Believed to occur is some systemic conditions such as seb dermatitis (fungus), atopy, rosaceaHyposecretory: decrease without obstruction. No published verified evidence, but assoc. clinically w/ gland atrophy. Decreased # of functional glands proportional to the duration of contact lens wear.
  • #8: 3. Stabilize tear film by reducing surface tension4. Enhance spreading over aqueous surface by presence of surfactant lowering surface tension. Surfactant also found in lacrimal glands, conjunctival epithelial cells, nasolacrimal system, auditory canal, lungs. More likely that the lipid layer collapses and expands with each blink than is actually re-spread with each blink.
  • #10: EDES and ADDES are not mutually exclusive and symptoms do not necessarily specify a subtype of dry eye
  • #11: UL tarsal plate: 10mm, LL: 5mmUL vs. LL production insufficiently investigated. LL focused on more due to easier accessibility to lower lids, especially w/ meibometry. Also, meibum from UL and LL mixed together during blinks so difficult to eval where it was produced.
  • #12: Acini are constantly making new meibocytes, leading to constant production of meibum. Supported by increased amount of lipids in morning after sleep….less dryness in morning, seborrhea worse in mornings. Constant secretion increases pressure within an obstructed gland. Recovery time 2hrs…may be best to do WC and digital expressions at bedtime instead of mornings.
  • #13: Bacterial lipases from commensal bacteria disrupt lipid formation, increasing melting point and leading to high viscosity lipid that mixes with desquamated epithelial cells, causing obstruction. Hormonal disturbances may also alter lipid production. Histology studies have shown lack of inflammatory leukocytes, chemokines and cytokines; indicating inflammation doesn’t represent a major etiologic factor in obstructive MGD, but rather part of a cascade of events to follow.
  • #21: Normal tear meniscus: 0.34mm above lid margin w/ white lightOCT depth: 200 microns depth from personal experience
  • #33: Low water content better for dry eyes. But high water content allows better continuity of lipid layer coverage.